Huaren Pharmaceutical Co., Ltd.
SHZ: 300110.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jian Lin
- Employees
- 2,681
- Headquarters
- Qingdao, China
- IPO year
- 2010
- Market cap
- CN¥3.7B
- Website
- https://www.qdhuaren.com
Loading 300110…
Loading profile data…Frequently asked questions about 300110
What does Huaren Pharmaceutical Co., Ltd. (300110.SZ) do?
Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. The company offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and st...
Where does 300110.SZ trade?
Huaren Pharmaceutical Co., Ltd. (300110.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300110.SZ in?
Huaren Pharmaceutical Co., Ltd. (300110.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Huaren Pharmaceutical Co., Ltd.?
Jian Lin is the chief executive officer of Huaren Pharmaceutical Co., Ltd. (300110.SZ).
Where is Huaren Pharmaceutical Co., Ltd. headquartered?
Huaren Pharmaceutical Co., Ltd. is headquartered in China.
Does 300110.SZ pay a dividend?
Yes — Huaren Pharmaceutical Co., Ltd. (300110.SZ) paid a trailing twelve-month dividend of CNY 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300110.SZ go public?
Huaren Pharmaceutical Co., Ltd. (300110.SZ) completed its initial public offering in 2010.